In-stent restenosis: Therapy and prevention

被引:0
|
作者
Radke, PW [1 ]
vom Dahl, J [1 ]
Klues, HG [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Klinikum, Med Klin 1, D-52057 Aachen, Germany
关键词
in-stent restenosis; therapy; prevention;
D O I
10.1007/BF03044706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In-stent restenosis has become a significant problem for interventional cardiologists. Due to different pathogenic causes it remains unclear whether a uniform therapeutic regimen is appropriate. Treatment: Redilatation has predominantly been used for the treatment of in stent restenosis, however, in long and diffuse restenotic stents, long-term results are reported to be poor. Therefore, tissue-debulking techniques may have beneficial effects in complex cases of in-stent restenosis. The therapeutic benefit fit of intracoronary radiation, local drug delivery or gene transfer has not been evaluated so far. Prevention: Therefore, prevention of the iatrogenic entity in-stent restenosis has become more important.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 50 条
  • [21] Prevention of coronary in-stent restenosis and vein graft failure: Does vascular gene therapy have a role?
    Robertson, Keith E.
    McDonald, Robert A.
    Oldroyd, Keith G.
    Nicklin, Stuart A.
    Baker, Andrew H.
    PHARMACOLOGY & THERAPEUTICS, 2012, 136 (01) : 23 - 34
  • [22] Long-term effects of octreotide therapy on in-stent restenosis
    Kursaklioglu, SH
    Iyisoy, A
    Amasyali, B
    Barcin, C
    Kose, S
    Celik, T
    Kilic, A
    Ozturk, C
    Demirtas, E
    HEART AND VESSELS, 2003, 18 (03) : 130 - 135
  • [23] Long-term effects of octreotide therapy on in-stent restenosis
    S. Hurkan Kursaklioglu
    Atila Iyisoy
    Basri Amasyali
    Cem Barcin
    Sedat Kose
    Turgay Celik
    Ayhan Kilic
    Cengiz Ozturk
    Ertan Demirtas
    Heart and Vessels, 2003, 18 : 130 - 135
  • [24] An overview of in-stent restenosis in iliofemoral venous stents
    Saleem, Taimur
    Raju, Seshadri
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (02) : 492 - +
  • [25] Treatment of In-Stent Restenosis When the Stent Is No Longer There
    Antuna, Paula
    Cuesta, Javier
    Garcia-Guimaraes, Marcos
    Bastante, Teresa
    De Rueda, Clemencia
    Rivero, Fernando
    Alfonso, Fernando
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (07) : E53 - E55
  • [26] Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?
    Kyaw, Htoo
    Johal, Gurpreet
    Gedela, Maheedhar
    Barman, Nitin
    Kini, Annapoorna
    Sharma, Samin K.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (11)
  • [27] In-Stent Restenosis in the Drug-Eluting Stent Era
    Dangas, George D.
    Claessen, Bimmer E.
    Caixeta, Adriano
    Sanidas, Elias A.
    Mintz, Gary S.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (23) : 1897 - 1907
  • [28] Nanoengineered Stent Surface to Reduce In-Stent Restenosis in Vivo
    Nuhn, Harald
    Blanco, Cesar E.
    Desai, Tejal A.
    ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (23) : 19677 - 19686
  • [29] Stent-Restenose: Therapiekonzepte und Möglichkeiten der PräventionIn-stent restenosis: Therapy and prevention
    Peter W. Radke
    Jürgen vom Dahl
    Heinrich G. Klues
    Medizinische Klinik, 1999, 94 (2) : 88 - 92
  • [30] In-stent restenosis and longitudinal stent deformation: a case report
    Si, Daoyuan
    Tong, Yaliang
    Yu, Bo
    He, Yuquan
    Liu, Guohui
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)